Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 16:12:2531-2541.
doi: 10.2147/IDR.S213183. eCollection 2019.

Augmented renal clearance is associated with inadequate antibiotic pharmacokinetic/pharmacodynamic target in Asian ICU population: a prospective observational study

Chien-Chih Wu  1   2 , Chih-Hsun Tai  1 , Wen-You Liao  2 , Chi-Chuan Wang  2 , Ching-Hua Kuo  2 , Shu-Wen Lin  1   3 , Shih-Chi Ku  4
Affiliations

Augmented renal clearance is associated with inadequate antibiotic pharmacokinetic/pharmacodynamic target in Asian ICU population: a prospective observational study

Chien-Chih Wu et al. Infect Drug Resist. .

Abstract

Background: Augmented renal clearance (ARC) is common in critically ill patients and could result in subtherapeutic antibiotic concentration. However, data in the Asian population are still lacking. The aim of this study was to explore the incidence and risk factors of ARC and its effect on β-lactam pharmacokinetics/pharmacodynamics (PK/PD) in Asian populations admitted to a medical ICU. In addition, we evaluated the appropriateness of using three estimated glomerular filtration (eGFR) formulas [Cockcroft-Gault (CG), Modification of Diet in Renal Disease (MDRD), and the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)] as screening tools.

Methods: We measured 2-, 8-, and 24-hr creatinine clearance (CLCr) and calculated eGFR by using three formulas for each. ARC was defined as CLCr24hr >130 mL/min/1.73 m2. Concentrations at the mid-dosing interval and prior to the next dose were collected if patients received the β-lactam antibiotic of piperacillin/tazobactam, cefepime, and meropenem, to determine the PK/PD index of fT > MIC. Multiple logistic regression analysis was conducted to identify the risk factors for ARC. Pearson correlation coefficient and the Bland and Altman method were applied to assess the accuracy of CLCr2hr, CLCr8hr, and eGFR for predicting ARC.

Results: Of 100 patients, 46 (46%) manifested ARC. Younger age (<50 years) and lower Sequential Organ Failure Assessment score increased the likelihood of ARC. ARC resulted in a low chance of achieving 50% fT >4MIC (33% vs 75%, p<0.01), 100% fT > MIC (23% vs 69%, p<0.01), and 100% fT >4MIC (3% vs 25%, p<0.02). CLCr8hr wielded the best correlation and agreement with CLCr24hr. eGFRCG was the most appropriate screening tool, and the optimal cutoff value for detecting ARC was 130.5 mL/min/1.73 m2.

Conclusion: ARC is associated with inadequate β-lactam PK/PD target in Asian ICU.

Keywords: augmented renal clearance (ARC); critical care; glomerular filtration rate; pharmacokinetic/pharmacokinetics; β-lactam antibiotic.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Targets of pharmacokinetic and pharmacodynamic attainment. *p<0.05. (A) piperacillin/tazobactam, (B) cefepime, (C) meropenem, (D) all β-lactam.
Figure 2
Figure 2
Correlations among measured creatinine clearances and various estimated glomerular filtration rates. (A) CLCr2hr vs CLCr24hr. (B) CLCr8hr vs CLCr24hr. (C) GFRCG vs CLCr24hr. (D) GFRMDRD vs CLCr24hr. (E) GFRCKD-EPI vs CLCr24hr.
Figure 3
Figure 3
Measurement of bias and agreement among measured creatinine clearances and various estimated glomerular filtration rates. (A) CLCr2hr vs CLCr24hr. (B) CLCr8hr vs CLCr24hr. (C) GFRCG vs CLCr24hr. (D) GFRMDRD vs CLCr24hr. (E) GFRCKD-EPI vs CLCr24hr.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Roberts JA, Abdul-Aziz MH, Lipman J, et al. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis. 2014;14(6):498–509. doi:10.1016/S1473-3099(14)70036-2 - DOI - PMC - PubMed
    1. Udy AA, Roberts JA, Boots RJ, Paterson DL, Lipman J. Augmented renal clearance: implications for antibacterial dosing in the critically ill. Clin Pharmacokinet. 2010;49(1):1–16. doi:10.2165/11318140-000000000-00000 - DOI - PubMed
    1. Udy AA, Baptista JP, Lim NL, et al. Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations. Crit Care Med. 2014;42(3):520–527. doi:10.1097/CCM.0000000000000029 - DOI - PubMed
    1. Carrie C, Petit L, d’Houdain N, et al. Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of beta-lactams administered by continuous infusion: a prospective observational study. Int J Antimicrob Agents. 2018;51(3):443–449. doi:10.1016/j.ijantimicag.2017.11.013 - DOI - PubMed
    1. Ruiz S, Minville V, Asehnoune K, et al. Screening of patients with augmented renal clearance in ICU: taking into account the CKD-EPI equation, the age, and the cause of admission. Ann Intensive Care. 2015;5(1):49. doi:10.1186/s13613-015-0090-8 - DOI - PMC - PubMed